Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis B news

Show

From To
NICE issues draft guideline for consultation on the diagnosis and management of hepatitis B

NICE is currently developing a new clinical guideline on the diagnosis and management of chronic hepatitis B in children, young people and adults. Draft recommendations have been published on the NICE website today (17 January) for public consultation.

Published
17 January 2013
From
NICE press release
New NICE public health guidance aims to ensure more people at increased risk of hepatitis B and C infection are tested

New guidance published today (12 December) by healthcare guidance body NICE highlights the need to tackle ignorance about the risk factors and causes of hepatitis B and C, and misconceptions about its treatment if barriers to effective testing of those at increased risk of infection are to be overcome.

Published
12 December 2012
From
NICE
European Commission approves Viread ® for HIV-1 infection in children and adolescents and for chronic hepatitis B in adolescents

New oral granule formulation and lower-strength tablets available for new indications.

Published
28 November 2012
From
Gilead press release
Copy of European Commission approves Viread ® for HIV-1 infection in children and adolescents and for chronic hepatitis B in adolescents

New oral granule formulation and lower-strength tablets available for new indications.

Published
28 November 2012
From
Gilead press release
Copy of FDA panel wants more info about hep B vaccine

An FDA advisory committee voted 13-1 in support of the efficacy of a hepatitis B vaccine on Thursday but questioned its safety and lack of information on its effects among certain minorities.

Published
19 November 2012
From
MedPage Today
FDA panel wants more info about hep B vaccine

An FDA advisory committee voted 13-1 in support of the efficacy of a hepatitis B vaccine on Thursday but questioned its safety and lack of information on its effects among certain minorities.

Published
19 November 2012
From
MedPage Today
Discoveries hold promise for treatment of Hepatitis B virus

A research team has discovered two prime targets of the Hepatitis B virus in liver cells, findings that could lead to treatment of liver disease in some of the 400 million people worldwide currently infected with the virus.

Published
23 October 2012
From
Science Daily
Tenofovir Is Safe and Effective for Treating Hepatitis B in Adolescents

Teenagers with chronic hepatitis B virus (HBV) infection responded well to 2 years of treatment with tenofovir (Viread) in the first study of the drug in this population, researchers reported in the August 27, 2012, advance online edition of Hepatology.

Published
27 September 2012
From
HIVandHepatitis.com
Viread labeling updates

The Viread label was updated to include dosing information for the treatment of chronic hepatitis B infection in patients 12 years of age and older, and to add 240 week data in adults to the package insert.

Published
30 August 2012
From
EATG
Hepatitis C-The "Diabetes-Curious" and Self Inkers/Piercers at Risk

Viral hepatitis B and C, which can cause life-threatening damage to the liver, can be the unintended consequence of two recent social trends: diabetes curiosity and self-inking/piercing. 'Diabetes curiosity' refers to those who use someone else’s lancet and glucose meter diabetes testing devices to prick themselves to test their own blood sugar levels. Self-inkers/piercers are people who use needles or other devices to create tattoos or pierce themselves or friends. In both cases, a life-threatening hepatitis infection can spread quickly from one person to another. “We have concerns about people borrowing someone else’s diabetes testing equipment to see what their own blood sugar levels are,” said State Epidemiologist Tim Jones, MD. “With these devices now commonplace, the testing process can generate curiosity. Parents need to know and remind children who use the devices not to share them with others, and parents of non-diabetic children should teach everyone in their family to never, ever experiment with another person’s insulin-related equipment.”

Published
22 August 2012
From
HCV New Drugs Research

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.